Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 131

Similar articles for PubMed (Select 20302428)

1.

Economic burden of ventilator-associated pneumonia based on total resource utilization.

Restrepo MI, Anzueto A, Arroliga AC, Afessa B, Atkinson MJ, Ho NJ, Schinner R, Bracken RL, Kollef MH.

Infect Control Hosp Epidemiol. 2010 May;31(5):509-15. doi: 10.1086/651669.

PMID:
20302428
2.

Silver-coated endotracheal tubes and incidence of ventilator-associated pneumonia: the NASCENT randomized trial.

Kollef MH, Afessa B, Anzueto A, Veremakis C, Kerr KM, Margolis BD, Craven DE, Roberts PR, Arroliga AC, Hubmayr RD, Restrepo MI, Auger WR, Schinner R; NASCENT Investigation Group.

JAMA. 2008 Aug 20;300(7):805-13. doi: 10.1001/jama.300.7.805.

PMID:
18714060
3.

Length of stay and hospital costs associated with a pharmacodynamic-based clinical pathway for empiric antibiotic choice for ventilator-associated pneumonia.

Nicasio AM, Eagye KJ, Kuti EL, Nicolau DP, Kuti JL.

Pharmacotherapy. 2010 May;30(5):453-62. doi: 10.1592/phco.30.5.453.

PMID:
20411997
4.

Economic impact of ventilator-associated pneumonia in a large matched cohort.

Kollef MH, Hamilton CW, Ernst FR.

Infect Control Hosp Epidemiol. 2012 Mar;33(3):250-6. doi: 10.1086/664049. Epub 2012 Jan 17.

PMID:
22314062
5.

Long-term medical utilization following ventilator-associated pneumonia in acute stroke and traumatic brain injury patients: a case-control study.

Yang CC, Shih NC, Chang WC, Huang SK, Chien CW.

BMC Health Serv Res. 2011 Oct 31;11:289. doi: 10.1186/1472-6963-11-289.

6.

Association between a silver-coated endotracheal tube and reduced mortality in patients with ventilator-associated pneumonia.

Afessa B, Shorr AF, Anzueto AR, Craven DE, Schinner R, Kollef MH.

Chest. 2010 May;137(5):1015-21. doi: 10.1378/chest.09-0391. Epub 2009 Dec 28.

PMID:
20038737
7.

Cost-effectiveness analysis of a silver-coated endotracheal tube to reduce the incidence of ventilator-associated pneumonia.

Shorr AF, Zilberberg MD, Kollef M.

Infect Control Hosp Epidemiol. 2009 Aug;30(8):759-63. doi: 10.1086/599005.

PMID:
19538095
8.

Impact of superinfection on hospital length of stay and costs in patients with ventilator-associated pneumonia.

Eagye KJ, Nicolau DP, Kuti JL.

Semin Respir Crit Care Med. 2009 Feb;30(1):116-23. doi: 10.1055/s-0028-1119815. Epub 2009 Feb 6. Review.

PMID:
19199193
9.

Epidemiology of ventilator-associated pneumonia in a long-term acute care hospital.

Walkey AJ, Reardon CC, Sulis CA, Nace RN, Joyce-Brady M.

Infect Control Hosp Epidemiol. 2009 Apr;30(4):319-24. doi: 10.1086/596103.

PMID:
19245314
10.

Outcome and attributable cost of ventilator-associated pneumonia among intensive care unit patients in a suburban medical center.

Warren DK, Shukla SJ, Olsen MA, Kollef MH, Hollenbeak CS, Cox MJ, Cohen MM, Fraser VJ.

Crit Care Med. 2003 May;31(5):1312-7.

PMID:
12771596
11.

Morbidity and cost burden of methicillin-resistant Staphylococcus aureus in early onset ventilator-associated pneumonia.

Shorr AF, Tabak YP, Gupta V, Johannes RS, Liu LZ, Kollef MH.

Crit Care. 2006;10(3):R97. Epub 2006 Jun 29.

12.

Bacteremia in patients with ventilator-associated pneumonia is associated with increased mortality: A study comparing bacteremic vs. nonbacteremic ventilator-associated pneumonia.

Agbaht K, Diaz E, Muñoz E, Lisboa T, Gomez F, Depuydt PO, Blot SI, Rello J.

Crit Care Med. 2007 Sep;35(9):2064-70.

PMID:
17581489
13.

Economic burden of ventilator-associated pneumonia in a developing country.

Alp E, Kalin G, Coskun R, Sungur M, Guven M, Doganay M.

J Hosp Infect. 2012 Jun;81(2):128-30. doi: 10.1016/j.jhin.2012.03.006. Epub 2012 May 1.

PMID:
22552163
15.

Relationship between glycemic control and diabetes-related hospital costs in patients with type 1 or type 2 diabetes mellitus.

Menzin J, Korn JR, Cohen J, Lobo F, Zhang B, Friedman M, Neumann PJ.

J Manag Care Pharm. 2010 May;16(4):264-75.

16.

Epidemiology and outcomes of ventilator-associated pneumonia in a large US database.

Rello J, Ollendorf DA, Oster G, Vera-Llonch M, Bellm L, Redman R, Kollef MH; VAP Outcomes Scientific Advisory Group.

Chest. 2002 Dec;122(6):2115-21.

PMID:
12475855
17.

The business case for preventing ventilator-associated pneumonia in pediatric intensive care unit patients.

Brilli RJ, Sparling KW, Lake MR, Butcher J, Myers SS, Clark MD, Helpling A, Stutler ME.

Jt Comm J Qual Patient Saf. 2008 Nov;34(11):629-38.

PMID:
19025083
18.

A prospective study of ventilator-associated pneumonia in children.

Srinivasan R, Asselin J, Gildengorin G, Wiener-Kronish J, Flori HR.

Pediatrics. 2009 Apr;123(4):1108-15. doi: 10.1542/peds.2008-1211.

PMID:
19336369
19.

Cost of a ventilator-associated pneumonia in a shock trauma intensive care unit.

Cocanour CS, Ostrosky-Zeichner L, Peninger M, Garbade D, Tidemann T, Domonoske BD, Li T, Allen SJ, Luther KM.

Surg Infect (Larchmt). 2005 Spring;6(1):65-72.

PMID:
15865552
20.

An open-labelled randomized controlled trial comparing costs and clinical outcomes of open endotracheal suctioning with closed endotracheal suctioning in mechanically ventilated medical intensive care patients.

David D, Samuel P, David T, Keshava SN, Irodi A, Peter JV.

J Crit Care. 2011 Oct;26(5):482-8. doi: 10.1016/j.jcrc.2010.10.002. Epub 2010 Nov 23.

PMID:
21106340
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk